Table 1 Characteristics of study groups related to CSC.

Patient no.	Age	Gender	Predisposing systemic factors	CSC subtype	No of leaks in FA during active phase	Treatment history
1	50	M	None	Recurrent	Unifocal	MRA
2	28	M	None	Inactive	Unifocal	No treatment
3	52	F	None	Inactive	Unifocal	No treatment
4	46	F	None	Inactive	Unifocal	Anti-VEGF
5	73	M	CHD	Chronic	Multifocal	No treatment
6	60	M	HTN, CHD	Inactive	Multifocal	Anti-VEGF
7	56	M	CHD	Recurrent	Unifocal	MRA
8	36	M	None	Recurrent	Unifocal	Focal laser
9	44	M	None	Recurrent	Multifocal	Focal laser, anti-VEGF
10	67	M	HTN	Chronic	Multifocal	Anti-VEGF
11	56	M	None	Inactive	Unifocal	Anti-VEGF
12	45	M	None	Inactive	Unifocal	No treatment
13	76	M	HTN	Chronic	Multifocal	Anti-VEGF
14	33	F	Pregnancy	Acute	NA^a	No treatment
15	35	F	Pregnancy	Inactive	NA^a	No treatment

CSC central serous chorioretinopathy, MRA mineralocorticoid receptor antagonist, VEGF vascular endothelial growth factor, CHD coronary heart disease, HTN hypertension. ^aFA was not performed because of pregnancy.

Quick links

Search